JSW
BIIB icon

Journey Strategic Wealth’s Biogen BIIB Stock Holding History

Journey Strategic Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Buy
1,589
+149
+10% +$27.5K 0.01% 559
2025
Q4 		$253K Buy
+1,440
New +$235K 0.01% 585

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Journey Strategic Wealth's BIIB Position: Q1 2026 in Review

Journey Strategic Wealth increased its Biogen (BIIB) stake by 10% in Q1 2026, buying an estimated $27.5K and bringing the position to 1,589 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #559.

Journey Strategic Wealth first reported a position in BIIB in Q4 2025 and has held it in 2 quarters since. 1,005 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Journey Strategic Wealth held 1,589 shares of Biogen worth $291K as of Q1 2026.
  • Journey Strategic Wealth bought 149 Biogen shares in Q1 2026, an estimated $27.5K.
  • Biogen made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #559 holding.
  • Journey Strategic Wealth first reported a position in Biogen in Q4 2025 and has held it in 2 quarters since.
  • 1,005 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.